Brief: Immunovia Q4 Operating Loss Widens To SEK 38.1 Mln
17/02/2021 15:03
Feb 17 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA FULL YEAR REPORT 2020
* Q4 NET SALES SEK 152,000 VERSUS SEK 45,000 YEAR AGO
* Q4 OPERATING LOSS SEK 38.1 MILLION VERSUS LOSS SEK 29.6
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr3Qt1CX
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study